Germany Boosts Spending on Space

The money represents an increase of 6 percent over 1987, compared with a 4 percent rise in the government’s overall science budget. Sectors due to receive a reduced share of the $4.7 billion budget include research into the use of coal and other fossil fuels (down 10.5 percent) and nuclear fission technology (down 15.3 percent). Biotechnology (up 7.7 percent), oceanography (up 11 percent) and ecology (up 8 percent) are among the beneficiaries. Presenting his budget to the Bundestag, Re

Written byRichard Sietmann
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Presenting his budget to the Bundestag, Research and Technology Minister Heinz Riesenhuber cited “a stronger integration of Europe and the Western world generally” as the reason for greater spending on space research. He argued for greater international collaboration to counter “growing concern about protectionism and current discussion about the disadvantages of the free flow of technological information.” Riesenhuber also announced a 15 percent increase, to $55 million, to enhance the transfer of technology and knowledge from West Germany’s research institutes into the private sector.

Despite such increases, the government’s share of national R&D spending—up by 15 percent over the past six years, compared with a 45 percent rise in private industry—is likely to decline still further in 1988. One type of expenditure that has already fallen, to about half of its 1982 figure, is the direct allocation of government funds to industrial R&D—for example, as various types of subsidies to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies